PYRILAMINE SHOWS STATISTICALLY SIGNIFICANT EFFICACY FOR PREMENSTRUAL CRAMPS
This article was originally published in The Tan Sheet
Executive Summary
PYRILAMINE SHOWS STATISTICALLY SIGNIFICANT EFFICACY FOR PREMENSTRUAL CRAMPS in two studies submitted to FDA by the Nonprescription Drug Manufacturers Association to support the Category I (safe and effective) status of the ingredient. The pooled results of the studies, sponsored by Sterling Winthrop and Chattem, "found statistically significant differences between pyrilamine maleate and placebo" for average cramp cluster symptom scores (comprised of cramps and backache scores), 2.70 for pyrilamine versus 2.98 for placebo, during the four days prior to menstruation.